Michael Richman

Business Advisor at TBT Pharma

Mike is the CEO of NextCure, an immunooncology immuno-oncology company he took from startup to IPO. Previously, Mr. Richman served as the President and CEO of Amplimmune, which was acquired by AstraZeneca for $500M in 2013.

Org chart

This person is not in the org chart

Teams

This person is not in any teams

Related people

Elyse Cole
DiD Agency
Amber Pisoni
GIS Benefits, Inc.
Ljiljana Lazetic
U.S. Pharmacopeial Convention
Ashwin Ponugoti
Tenet Diagnostics
Andrea Van Den Boogaard
Chicago Council on Science and Technology

Michael Richman

Business Advisor at TBT Pharma

Org chart

Teams

Related people

Elyse Cole

Amber Pisoni

Ljiljana Lazetic

Ashwin Ponugoti

Andrea Van Den Boogaard